中药大品种科技竞争力报告(2018版)概要
|
摘要
当前,我国医药产业生态格局和行业运行规则正在剧变,中药产业面临新的挑战,以临床价值、科学价值为核心的科技创新驱动,成为中药产业高质量发展的关键推动力。科技竞争力集中体现了中成药产品的临床价值和科学价值,通过科技竞争力评价,有助于形成正确的价值导向,催生行业内生动力。项目组基于公开数据和评价模型,进行中药大品种科技竞争力评价,编制《中药大品种科技竞争力报告(2018版)》,全景式展示了中药大品种科技竞争力概况。本文包含全品类百强榜、非注射百强榜、各省区排行榜第一名、各治疗领域前三名等榜单。具有科技竞争力优势的中药大品种,正成为引领中药产业高质量发展的中坚力量。
At present,the ecological pattern and operation rules of the pharmaceutical industry in China are changing dramatically,the traditional Chinese medicine industry is facing new challenges. The scientific and technological innovation driven by clinical and scientific value has become the main driving force for the high-quality development of Chinese medicine industry. Scientific and technological competitiveness embodies the clinical and scientific value of Chinese patent medicine products. Through the evaluation of scientific and technological competitiveness,it is helpful to form the correct value orientation,and promote the endogenous power of the industry. Based on the open data and evaluation model,the project team carried out the evaluation of the scientific and technological competitiveness of large varieties of traditional Chinese medicine,and compiled the "Report on the Scientific and Technological Competitiveness of Large Varieties of Traditional Chinese Medicine( 2018 Edition) ",which panoramically displayed the general situation of the scientific and technological competitiveness of large varieties of traditional Chinese medicine. The top 100 list of the whole category,the top 100 list of non-injection,the top one of the provinces and regions,and the top three of the treatment fields are included in this article. Large varieties of traditional Chinese medicine( TCM) with the advantage of scientific and technological competitiveness are becoming the backbone force leading the high-quality development of TCM industry.
At present,the ecological pattern and operation rules of the pharmaceutical industry in China are changing dramatically,the traditional Chinese medicine industry is facing new challenges. The scientific and technological innovation driven by clinical and scientific value has become the main driving force for the high-quality development of Chinese medicine industry. Scientific and technological competitiveness embodies the clinical and scientific value of Chinese patent medicine products. Through the evaluation of scientific and technological competitiveness,it is helpful to form the correct value orientation,and promote the endogenous power of the industry. Based on the open data and evaluation model,the project team carried out the evaluation of the scientific and technological competitiveness of large varieties of traditional Chinese medicine,and compiled the "Report on the Scientific and Technological Competitiveness of Large Varieties of Traditional Chinese Medicine( 2018 Edition) ",which panoramically displayed the general situation of the scientific and technological competitiveness of large varieties of traditional Chinese medicine. The top 100 list of the whole category,the top 100 list of non-injection,the top one of the provinces and regions,and the top three of the treatment fields are included in this article. Large varieties of traditional Chinese medicine( TCM) with the advantage of scientific and technological competitiveness are becoming the backbone force leading the high-quality development of TCM industry.
引文
[1]中药大品种联盟,万方数据,中华中医药学会研究与评价办公室.中药大品种科技竞争力报告(2018版)[R].北京:中华中医药学会,2018.
[2]肖小溪,程燕林,李晓轩.第三方科技评价前沿问题研究[J].中国科技论坛,2015(8):11-14.
[3]葛增柱,沈景新.技术产品的科技因素分析及价值评估[C].中国航空学会控制与应用学术年会,中国系统仿真学会仿真器第四届学术年会.北京:中国航空学会,1996:6-12.
[4]王永炎,杨洪军.中小型中药企业大品种培育策略与路径分析[J].中国中药杂志,2014,39(5):755-758.
[5]中药大品种联盟,万方数据,中华中医药学会研究与评价办公室.中药大品种科技竞争力报告(2017版)[R].广州:中华中医药学会,2017.
[6]莫美,张霄潇,于国华,等.中药大品种培育影响指标问卷调查报告[J].中国中药杂志,2015,40(22):4501-4505.
[7]中药大品种联盟,万方数据,中华中医药学会研究与评价办公室.中药大品种科技竞争力报告(2016版)[R].北京:中华中医药学会,2016.
[8]李耿,程煜华,郭宇博,等.中药大品种科技竞争力报告(2017版)[J].中国现代中药,2018,20(1):6-13.
[9]中国中医科学院中药资源中心,中药大品种联盟.2017年度中国云南灯盏花产业发展报告[R].昆明:中国中医科学院中药资源中心,2016.
[10]中华人民共和国国务院办公厅.关于完善国家基本药物制度的意见(国办发[2018]88号)[Z].2018-09-19.
[2]肖小溪,程燕林,李晓轩.第三方科技评价前沿问题研究[J].中国科技论坛,2015(8):11-14.
[3]葛增柱,沈景新.技术产品的科技因素分析及价值评估[C].中国航空学会控制与应用学术年会,中国系统仿真学会仿真器第四届学术年会.北京:中国航空学会,1996:6-12.
[4]王永炎,杨洪军.中小型中药企业大品种培育策略与路径分析[J].中国中药杂志,2014,39(5):755-758.
[5]中药大品种联盟,万方数据,中华中医药学会研究与评价办公室.中药大品种科技竞争力报告(2017版)[R].广州:中华中医药学会,2017.
[6]莫美,张霄潇,于国华,等.中药大品种培育影响指标问卷调查报告[J].中国中药杂志,2015,40(22):4501-4505.
[7]中药大品种联盟,万方数据,中华中医药学会研究与评价办公室.中药大品种科技竞争力报告(2016版)[R].北京:中华中医药学会,2016.
[8]李耿,程煜华,郭宇博,等.中药大品种科技竞争力报告(2017版)[J].中国现代中药,2018,20(1):6-13.
[9]中国中医科学院中药资源中心,中药大品种联盟.2017年度中国云南灯盏花产业发展报告[R].昆明:中国中医科学院中药资源中心,2016.
[10]中华人民共和国国务院办公厅.关于完善国家基本药物制度的意见(国办发[2018]88号)[Z].2018-09-19.